ClinicalTrials.Veeva

Menu

Vascular Infections Caused by Coxiella Burnetii (COXIVAS)

U

University Hospital of Bordeaux

Status

Not yet enrolling

Conditions

Vascular Infection Caused by C. Burnetii

Study type

Observational

Funder types

Other

Identifiers

NCT07305402
CHUBX 2025/024

Details and patient eligibility

About

high morbidity and mortality. In France, Coxiella burnetii-related vascular infections appear to be increasing, though data remain limited. Two-year mortality reaches 15-18%, mainly due to serious complications such as arterio-digestive fistulas. Diagnosis is often delayed, prognostic factors are poorly defined, and the value of advanced imaging techniques remains insufficiently studied.

Full description

Q fever is a worldwide zoonosis that may cause chronic vascular infections with significant morbidity and mortality. In France, the incidence of Coxiella burnetii-related vascular infections appears to be increasing, although published data remain scarce. Reported two-year mortality reaches 15-18%, largely due to severe complications such as arterio-digestive fistulas. Classical risk factors include aortic aneurysm and vascular grafts, but many patients present without clear zoonotic exposure, leading to frequent underdiagnosis. Prognostic factors are poorly defined, apart from the lack of surgical management, which worsens outcomes. Diagnosis is often delayed, and the value of advanced imaging modalities such as 18F-FDG PET/CT or labeled leukocyte scintigraphy remains insufficiently studied.

Enrollment

400 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults (≥ 18yrs old) with native or prosthetic vascular infection due to C. burnetii (Jan 2000 - Dec 2023)
  • diagnosis based on CNR vascular Q fever criteria,
  • supplemented by MAGIC (Management of Aortic Graft Infection Collaboration) criteria for prosthetic/ - endovascular infections or aortitis/arteritis criteria,
  • no objection to reuse of patient data.

Exclusion criteria

  • patient under legal protection,
  • insufficient French language comprehension

Trial design

400 participants in 1 patient group

Prosthetic vascular infection due to C. burnetii
Description:
Adults with native or prosthetic vascular infection due to C. burnetii

Trial contacts and locations

1

Loading...

Central trial contact

Zoe Blanc, MD; Mathilde Puges, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems